Advertisement
Screener

AMERICAN SHARED HOSPITAL SERVICES (AMS) Foreign Currency Transaction Loss, before Tax

2.8 / 5 stars · 68/120 Roast Me

AMERICAN SHARED HOSPITAL SERVICES Foreign Currency Transaction Loss, before Tax

AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Foreign Currency Transaction Loss, before Tax of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:ForeignCurrencyTransactionLossBeforeTax · last filed 2016-03-30

  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction loss, before tax for the quarter ending 2013-12-31 was $334.00K.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction loss, before tax for the quarter ending 2013-09-30 was $306.00K.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction loss, before tax for the quarter ending 2013-06-30 was $393.00K.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction loss, before tax for the quarter ending 2013-03-31 was $141.00K.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction loss, before tax for fiscal 2015 was $0.00.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction loss, before tax for fiscal 2013 was $1.17M.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction loss, before tax for fiscal 2012 was -$132.00K, a 588.89% decline from fiscal 2011.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction loss, before tax for fiscal 2011 was $27.00K.
Period endForeign Currency Transaction Loss, before Tax 3 monthForeign Currency Transaction Loss, before Tax 6 monthForeign Currency Transaction Loss, before Tax 9 monthForeign Currency Transaction Loss, before Tax 12 month
2015-12-31$0.00
10-K · filed 2016-03-30
2013-12-31$334.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$640.00K
derived: sum of 2 quarters · filed 2016-03-30
$1.03M
derived: sum of 3 quarters · filed 2016-03-30
$1.17M
10-K · filed 2016-03-30
2013-09-30$306.00K
10-Q · filed 2013-11-14
$699.00K
derived: sum of 2 quarters · filed 2013-11-14
$840.00K
10-Q · filed 2013-11-14
$708.00K
derived: sum of 4 quarters · filed 2014-05-15
2013-06-30$393.00K
10-Q · filed 2013-08-14
$534.00K
10-Q · filed 2013-08-14
$402.00K
derived: sum of 3 quarters · filed 2014-05-15
$402.00K
derived: sum of 4 quarters · filed 2014-05-15
2013-03-31$141.00K
10-Q · filed 2014-05-15
$9.00K
derived: sum of 2 quarters · filed 2014-05-15
$9.00K
derived: sum of 3 quarters · filed 2014-05-15
$9.00K
derived: sum of 4 quarters · filed 2014-05-15
2012-12-31-$132.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
-$132.00K
derived: sum of 2 quarters · filed 2014-03-31
-$132.00K
derived: sum of 3 quarters · filed 2014-03-31
-$132.00K
10-K · filed 2014-03-31
2012-09-30$0.00
10-Q · filed 2013-11-14
$0.00
derived: sum of 2 quarters · filed 2013-11-14
$0.00
10-Q · filed 2013-11-14
2012-06-30$0.00
10-Q · filed 2013-08-14
$0.00
10-Q · filed 2013-08-14
2011-12-31$27.00K
10-K · filed 2014-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45